CAV1 and acute respiratory distress syndrome: Furthermore, we further validated the roles of CAV-1 and NF-κBp65 in vivo and in vitro, while we also explored the potential mechanisms by which CAV-1 could provide novel targets for ALI treatment (Fig. 1A).